In one paragraphArticle in Briefings in bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
10 authors.
Daniel Toro-DomínguezGENYO. Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración 114, 18016, Granada, Spain.ORCID 0000-0001-8440-312X Jordi Martorell-MarugánGENYO. Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración 114, 18016, Granada, Spain.ORCID 0000-0002-5186-0735 Manuel Martinez-BuenoGENYO. Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración 114, 18016, Granada, Spain.
Raúl López-DomínguezGENYO. Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración 114, 18016, Granada, Spain.ORCID 0000-0001-8634-117X Elena Carnero-MontoroGENYO. Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración 114, 18016, Granada, Spain.
Guillermo BarturenGENYO. Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración 114, 18016, Granada, Spain.
Daniel GoldmanJohns Hopkins University School of Medicine, Baltimore, Maryland.
Michelle PetriJohns Hopkins University School of Medicine, Baltimore, Maryland.
Pedro Carmona-SáezGENYO. Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración 114, 18016, Granada, Spain.ORCID 0000-0002-6173-7255 Marta E Alarcón-RiquelmeGENYO. Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración 114, 18016, Granada, Spain.
Funding
Consejería de Transformación Económica, Industria, Conocimiento y UniversidadesFEDER and the Innovative Medicines Initiative 2 Joint Undertaking PID2020-119032RB-I00FEDER/Junta de Andalucía-Consejer'a de Transformación Económica, Industria, Conocimiento y Universidades P20_00335
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Lupus NephritisHumansautoimmunitymachine learningomics datapersonalized medicinesystemic lupus erythematosustranscriptomics
Identifiers
PMID38084921
PMCPMC10753528
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390